SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 539 filers reported holding SEAGEN INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $408,389 | -96.4% | 1,925 | -96.8% | 0.00% | -95.7% |
| Q2 2023 | $11,444,057 | -26.1% | 59,462 | -22.3% | 0.05% | -33.3% |
| Q1 2023 | $15,485,715 | +196.7% | 76,484 | +88.3% | 0.07% | +176.0% |
| Q4 2022 | $5,218,663 | +36.3% | 40,609 | +45.1% | 0.02% | +25.0% |
| Q3 2022 | $3,829,000 | +1795.5% | 27,980 | +1891.5% | 0.02% | +1900.0% |
| Q1 2022 | $202,000 | -95.2% | 1,405 | -94.9% | 0.00% | -93.8% |
| Q4 2021 | $4,249,000 | -83.0% | 27,486 | -81.3% | 0.02% | -86.0% |
| Q3 2021 | $24,945,000 | +4477.1% | 146,906 | +4155.7% | 0.11% | +5600.0% |
| Q2 2021 | $545,000 | -36.5% | 3,452 | -44.2% | 0.00% | -50.0% |
| Q1 2021 | $858,000 | -89.4% | 6,181 | -86.6% | 0.00% | -88.6% |
| Q4 2020 | $8,078,000 | – | 46,124 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,913,769 | $9,498,630,809 | 51.68% |
| Davide Leone & Partners Investment Co Ltd. | 151,000 | $30,572,970 | 36.44% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 200,200 | $40,510,470 | 11.30% |
| Eagle Health Investments LP | 174,902 | $35,412,408 | 6.89% |
| Nan Fung Group Holdings Ltd | 47,096 | $9,535,527 | 6.49% |
| Paradigm Biocapital Advisors LP | 281,969 | $57,090,263 | 5.41% |
| Avoro Capital Advisors LLC | 1,801,906 | $364,831,908 | 5.41% |
| Lagoda Investment Management, L.P. | 36,545 | $7,399,266 | 5.26% |
| Sand Grove Capital Management LLP | 190,396 | $38,549 | 5.21% |
| Athos Capital Ltd | 31,000 | $6,277 | 4.32% |